Oncología Hepática
University of Wuppertal
Wuppertal, AlemaniaUniversity of Wuppertal-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2023
-
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma (Frontiers in Pharmacology, (2023), 14, (1124214), 10.3389/fphar.2023.1124214)
Frontiers in Pharmacology
-
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
Frontiers in Pharmacology, Vol. 14